You are here

Oct 03, 2014

The 2014 Expoquimia prize in the category of Biotechnology has been awarded to Iproteos for the research on "IPR19: a new drug for the treatment of the cognitive impairment associated  with schizophrenia". Teresa Tarragó and Ernest Giralt, founders of Iproteos, received the prize from Luís Serrano, FEIQUE and Expoquimia President. The award recognises the biotechnological research on an original product or technology, with proven efficiency and in advanced stage for marketing.

Sep 30, 2014

The crowdfunding campaign of Iproteos has already achieved more than 70,000 € and is getting closer and closer to the final objective of 100,000 €. Finally, it will finish the 10th of October, coinciding with the World Mental Health day.

The project linked to the campaign is devoted to the completion of the non-regulatory preclinical trials of a novel therapy for Schizophrenia, a devastating disease that affects around 24 million people in the world and is usually established around ages of 15 to 35 years, according to the World Health Organization.

Sep 16, 2014

Iproteos has raised more than 55,000€ through crowdfunding for the development of a new Schizophrenia treatment. It is the first time that the equity crowdfunding is used in a Spanish biotechnological project and results are, so far, very promising. Having overcome the halfway point of the campaign, Iproteos is determined to achieve the 100,000€ by the end of September.

Jul 22, 2014

Iproteos will attend the BioSpain 2014, that will be held in Santiago de Compostela (Galicia) between the 24th and 26th of September. As in other editions, Iproteos will take profit of the partnering opportunities in order to find collaborators. If you are willing to form part of our network, please, do not hesitate to contact us. More information aboout BioSpain 2014 can be found at: Hope to see you there!

Jul 22, 2014

Professor Ernest Giralt, co-founder of Iproteos and SAB president, has been awarded with The Josef Rudinger Memorial Lecture Award. This recognized award honours a candidate with outstanding contributions to peptide chemistry. Prof. Giralt extense career has been devoted, among many other scientific challenges, to the development of peptide synthesis methodologies, peptide structure study and the use of peptides as shuttles.

Jul 04, 2014

Iproteos has been invited to give a speech at the Entrepreneurial Technology Fair 2014 that will be held on 9th of July. The goal of the event is to establish contacts and foster collaboration projects with students and old members of IESE. In total, six projects with clear focus to the commercialization of innovative technologies have been selected.